1. Home
  2. GNE vs RZLT Comparison

GNE vs RZLT Comparison

Compare GNE & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genie Energy Ltd. Class B Stock

GNE

Genie Energy Ltd. Class B Stock

N/A

Current Price

$16.66

Market Cap

408.2M

Sector

Utilities

ML Signal

N/A

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

N/A

Current Price

$4.02

Market Cap

471.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GNE
RZLT
Founded
2011
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
408.2M
471.0M
IPO Year
2011
2011

Fundamental Metrics

Financial Performance
Metric
GNE
RZLT
Price
$16.66
$4.02
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
★ $9.80
AVG Volume (30 Days)
50.1K
★ 1.4M
Earning Date
11-05-2026
11-17-2026
Dividend Yield
★ 1.80%
N/A
EPS Growth
★ 95.65
23.47
EPS
★ 0.54
N/A
Revenue
★ $425,202,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.86
$2,214.20
P/E Ratio
$30.89
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$12.69
$1.07
52 Week High
$17.11
$11.46

Technical Indicators

Market Signals
Indicator
GNE
RZLT
Relative Strength Index (RSI) 51.80 49.75
Support Level $15.80 $3.69
Resistance Level $16.89 $5.36
Average True Range (ATR) 0.49 0.27
MACD -0.06 0.02
Stochastic Oscillator 54.77 73.44

Price Performance

Historical Comparison
GNE
RZLT

About GNE Genie Energy Ltd. Class B Stock

Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.

Share on Social Networks: